Art
J-GLOBAL ID:201602294925681022   Reference number:16A0864961

Risk factors for joint symptoms in postmenopausal Japanese breast cancer patients treated with anastrozole: a prospective multicenter cohort study of patient-reported outcomes

アナストロゾールで治療した閉経後日本人乳癌患者における関節症状のリスク因子 患者報告転帰の前向き多施設コホート研究
Author (29):
Material:
Volume: 21  Issue:Page: 262-269  Publication year: Apr. 2016 
JST Material Number: L3966A  ISSN: 1341-9625  Document type: Article
Article type: 原著論文  Country of issue: Germany, Federal Republic of (DEU)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A0864961&from=J-GLOBAL&jstjournalNo=L3966A") }}
Author keywords (4):
JST classification (2):
JST classification
Category name(code) classified by JST.
Clinical application of antitumor(=antineoplastic)drugs  ,  Drug therapy(=pharmacotherapy)for tumors 
Substance index (1):
Substance index
Chemical Substance indexed to the Article.
Reference (11):
  • Kyvernitakis I, Ziller V, Hars O et al (2014) Prevalence of menopausal symptoms and their influence on adherence in women with breast cancer. Climacteric 17:252-259
  • Coates AS, Keshaviah A, Thürlimann B et al (2007) Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. J Clin Oncol 25:486-492
  • Howell A, Cuzick J, Baum M et al (2005) Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer. Lancet 365:60-62
  • Crew KD, Greenlee H, Capodice J et al (2007) Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol 25:3877-3883
  • Sestak I, Cuzick J, Sapunar F et al (2008) Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis. Lancet Oncol 9:866-872
more...

Return to Previous Page